Pharmacological Correlates of Jalaukavacharana: An Integrative Review of Leech Salivary Secretome Bioactivity in Classical Shalya Tantra Indications for Rakta-Dushti Disorders
DOI:
https://doi.org/10.63682/jns.v14i32S.10426Keywords:
Jalaukavacharana; Hirudo medicinalis; Raktamokshana; hirudin; leech salivary secretome; Shalya Tantra; hirudotherapy; Rakta-DushtiAbstract
Background: Jalaukavacharana, the therapeutic application of medicinal leeches, occupies a uniquely detailed position among the five classical methods of Raktamokshana. Acharya Sushruta devotes an entire chapter of Sutrasthana to leech classification, technique, and disease specific indication. Leech therapy has undergone a parallel clinical revival in contemporary medicine and is now an established adjunct in microsurgical and reconstructive practice, principally for relief of post-operative venous congestion. The therapeutic action in both traditions converges on the leech salivary secretome, a complex mixture of anticoagulant, antiplatelet, fibrinolytic, and anti-inflammatory bioactive molecules released during feeding.
Objective: This review correlates individually named Shalya Tantra indications for Jalaukavacharana with the specific salivary bioactive compounds plausibly responsible for the corresponding therapeutic effect, an exercise not previously undertaken in a structured, evidence graded format and not addressed by the single existing Ayurveda-biomedicine review of leech therapy.
Methods: A narrative and integrative review was conducted across PubMed, Scopus, Web of Science, the DHARA database, and the Cochrane Library, combined with manual reference screening of secondary Ayurvedic literature. Classical Sthana, Adhyaya, and Shloka citations were verified directly against primary published editions and, wherever available, against a second independently published secondary source citing the same edition; one citation that could not be corroborated on this verification was removed from the review. Sources were organised narratively into three domains, classical classification and indication, salivary compound pharmacology, and a qualitative convergence mapping between the two, following a synthesis approach informed by the reverse pharmacology framework applied elsewhere in Ayurveda-biomedicine integrative research. Reporting follows the SANRA criteria for narrative review articles.
Results: Twelve classically described leech types were identified, six Nirvisha and six Savisha, of which the six Nirvisha types are described as therapeutically usable. Five principal salivary bioactive classes were characterised in the modern literature, namely hirudin, hyaluronidase, calin, destabilase, and the Bdellin and Eglin protease inhibitor family, each with an increasingly well defined mechanism of action. A convergence analysis mapping six major classical indications to their most plausible salivary correlate showed strong mechanistic alignment for Vatarakta (hirudin mediated anticoagulation) and Shotha (hyaluronidase mediated interstitial spreading), with moderate to weak alignment for Kushtha, Visarpa, Netra Roga, and Shirashula, reflecting the more multifactorial classical pathophysiology of these conditions.
Conclusion: The disease specific prescriptions for Jalaukavacharana recorded in Shalya Tantra texts show a coherent, though not yet experimentally confirmed, correlation with the molecular pharmacology of the leech salivary secretome. This convergence provides a structured, testable framework for future comparative secretome research across the classically described Nirvisha leech types and for indication specific clinical evaluation
Downloads
References
1. Singh SK, Rajoria K. Medical leech therapy in Ayurveda and biomedicine: a review. J Ayurveda Integr Med. 2020;11(4):554-564. doi:10.1016/j.jaim.2018.09.003.
2. Sushruta. Sushruta Samhita, Sutrasthana, Jalaukavacharaniya Adhyaya 13. Edited by Jadavji Trikamji Acharya, with Dalhana's Nibandhasamgraha commentary. 8th ed. Varanasi: Chaukhambha Orientalia; 2005.
3. Agnivesha. Charaka Samhita, Sutrasthana, Vidhishonitiya Adhyaya 24, verses 11-18. Pandey G, editor, Vidyotini Hindi commentary, Vol. 1. Varanasi: Chaukhamba Sanskrit Sansthan; 2006, pp. 444-445.
4. Dalhana. Nibandhasamgraha commentary on Sushruta Samhita, Sutrasthana, Jalokavacharaniya Adhyaya 13, verses 11-12 and 15-17. Trikamji Acharya Y, editor. 6th ed. Varanasi: Chaukhamba Orientalia; 1997, pp. 44-57.
5. Vagbhata. Ashtanga Hridaya, Sutrasthana, Shastravidhi Adhyaya 26. Hindi commentary by Brahmananda Tripathi. Varanasi: Chaukhamba Surbharati Prakashan; 2013.
6. Sharangadhara. Sharangadhara Samhita, Uttara Khanda, Shonitasravavidhi Adhyaya 12, verses 19-22. Vidyasagar PS, editor, with Adhamalla's Dipika and Kashiram's Gudhartha-Dipika commentaries. Varanasi: Surbharati Prakashana; 2006, pp. 622-623.
7. Hackenberger PN, Janis JE. A comprehensive review of medicinal leeches in plastic and reconstructive surgery. Plast Reconstr Surg Glob Open. 2019;7(12):e2555. doi:10.1097/GOX.0000000000002555.
8. US Food and Drug Administration. FDA approves leeches as a device for skin grafts and reattachment surgery [news release]. Rockville, MD: FDA; July 1, 2004.
9. Chen J, Xie X, Zhang H, Li G, Yin Y, Cao X, Gao Y, Li Y, Zhang Y, Fu P, Cheng P. Pharmacological activities and mechanisms of hirudin and its derivatives: a review. Front Pharmacol. 2021;12:660757. doi:10.3389/fphar.2021.660757.
10. US Food and Drug Administration. 510(k) Premarket Notification K040187, Ricarimpex SAS, Medicinal Leeches. Silver Spring, MD: FDA; 2004.
11. Munro R, Jones CP, Sawyer RT. Calin, a platelet adhesion inhibitor from the saliva of the medicinal leech. Blood Coagul Fibrinolysis. 1991;2(1):179-184. doi:10.1097/00001721-199102000-00027.
12. Baskova IP, Nikonov GI. Destabilase, the novel epsilon-(gamma-Glu)-Lys isopeptidase with thrombolytic activity. Blood Coagul Fibrinolysis. 1991;2(1):167-172. doi:10.1097/00001721-199102000-00025.
13. Fronza M, Caetano GF, Leite MN, Bitencourt CS, Paula-Silva FW, Andrade TA, Frade MA, Merfort I, Faccioli LH. Hyaluronidase modulates inflammatory response and accelerates the cutaneous wound healing. PLoS One. 2014;9(11):e112297. doi:10.1371/journal.pone.0112297.
14. Whitaker IS, Izadi D, Oliver DW, Monteath G, Butler PE. Hirudo medicinalis and the plastic surgeon. Br J Plast Surg. 2004;57(4):348-353. doi:10.1016/j.bjps.2003.12.016.
15. Dodt J, Müller HP, Seemüller U, Chang JY. The complete amino acid sequence of hirudin, a thrombin specific inhibitor. Application of colour carboxymethylation. FEBS Lett. 1984;165(2):180-184. doi:10.1016/0014-5793(84)80165-2.
16. Stone SR, Hofsteenge J. Kinetics of the inhibition of thrombin by hirudin. Biochemistry. 1986;25(16):4622-4628. doi:10.1021/bi00364a025.
17. Van Alphen NA, Gonzalez A, McKenna MC, McKenna TK, Carlsen BT, Moran SL. Ciprofloxacin resistant Aeromonas infection following leech therapy for digit replantation: report of 2 cases. J Hand Surg Am. 2014;39(3):499-502. doi:10.1016/j.jhsa.2013.11.041.
18. Patwardhan B, Vaidya ADB, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci. 2004;86(6):789-799.
19. Seemüller U, Dodt J, Fink E, Fritz H. Proteinase inhibitors of the leech Hirudo medicinalis (hirudins, bdellins, eglins). In: Barrett AJ, Salvesen G, eds. Proteinase Inhibitors. Amsterdam: Elsevier; 1986:337-359.
20. Baskova IP, Zavalova LL. Proteinase inhibitors from the medicinal leech Hirudo medicinalis. Biochemistry (Mosc). 2001;66(7):703-714.
21. Hildebrandt JP, Lemke S. Small bite, large impact: saliva and salivary molecules in the medicinal leech, Hirudo medicinalis. Naturwissenschaften. 2011;98(12):995-1008. doi:10.1007/s00114-011-0859-z.
22. Baethge C, Goldbeck-Wood S, Mertens S. SANRA, a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5. doi:10.1186/s41073-019-0064-8.
23. Babenko VV, Podgorny OV, Manuvera VA, Kasianov AS, Manolov AI, Grafskaia EN, et al. Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches. BMC Genomics. 2020;21:331. doi:10.1186/s12864-020-6748-0.
24. Shi P, Wei J, You H, Chen S, Tan F, Lu Z. Cloning, characterization, and heterologous expression of a candidate Hirudin gene from the salivary gland transcriptome of Hirudo nipponia. Sci Rep. 2023;13:4943. doi:10.1038/s41598-023-32303-2.
25. Kim JH, Lee CJ, Yu YS, Aryal YP, Kim S, Suh JY, et al. Transcriptomic profiling and the first spatial expression analysis of candidate genes in the salivary gland of the East Asian medicinal leech, Hirudo nipponia. Dev Comp Immunol. 2024;154:105125. doi:10.1016/j.dci.2023.105125.
26. Zheng J, Wang X, Feng T, Rehman SU, Yan X, Shan H, et al. Molecular mechanisms underlying hematophagia revealed by comparative analyses of leech genomes. GigaScience. 2023;12:giad023. doi:10.1093/gigascience/giad023.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.